| Literature DB >> 28589077 |
Xuan Liu1, Surui Wu1, Jiao Xu1, Chun Sui1, Jianhe Wei1.
Abstract
The CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) system was first identified in bacteria and archaea and can degrade exogenous substrates. It was developed as a gene editing technology in 2013. Over the subsequent years, it has received extensive attention owing to its easy manipulation, high efficiency, and wide application in gene mutation and transcriptional regulation in mammals and plants. The process of CRISPR/Cas is optimized constantly and its application has also expanded dramatically. Therefore, CRISPR/Cas is considered a revolutionary technology in plant biology. Here, we introduce the mechanism of the type II CRISPR/Cas called CRISPR/Cas9, update its recent advances in various applications in plants, and discuss its future prospects to provide an argument for its use in the study of medicinal plants.Entities:
Keywords: CRISPR/Cas system; Gene editing technology; Gene modification; Plant biology; Transcriptional regulation
Year: 2017 PMID: 28589077 PMCID: PMC5443236 DOI: 10.1016/j.apsb.2017.01.002
Source DB: PubMed Journal: Acta Pharm Sin B ISSN: 2211-3835 Impact factor: 11.413
Comparison of ZFN, TALEN, CRISPR/Cas9 and NgAgo11, 12.
| Technology | DNA binding determinant | Endonuclease | Mutation rate (%) | Target site length (bp) | Binding specificity | Off-targeting | Application |
|---|---|---|---|---|---|---|---|
| ZFN | Zinc finger protein | FokI | 10 | 18–36 | 3 Nucleotides | High | Human cells, pig, mice, tobacco, nematode and zebrafish |
| TALEN | Transcription-activator-like effector | FokI | 20 | 30–40 | 1 Nucleotide | Low | Human cells, water flea, cow and mice |
| CRISPR/Cas9 | crRNA/sgRNA | Cas9 | 20 | 22 | 1:1 Nucleotide pairing | Variable | Human cells, wheat, rice, maize and
|
| NgAgo-gDNA | 5′ phosphorylated ssDNA | NgAgo | 21.3–41.3 | 24 | 1:1 Nucleotide pairing | Low | Human cells |
List of CRISPR/Cas9 gene editing in plants.
| Plant | Target gene | Cas9 version | Cas9 promoter | sgRNA promoter | Delivery method | Editing method | Mutation frequency (%) | Ref. |
|---|---|---|---|---|---|---|---|---|
| Human codon-optimized Cas9 | 2×35S | AtU6-26 | NHEJ | 30—84 | ||||
| A non-functional | CaMV 35S | AtU6-26 | NHEJ | N/A | ||||
| Plant codon-optimized Cas9 | 35 SPPDK | AtU6 | NHEJ | 1.1—7.7 | ||||
| Human codon-optimized Cas9 | OsUBQ1 | OsU3 | NHEJ | 10—89 | ||||
| PcUbi4-2 | AtU6-26 | NHEJ | 2.5—70.0 | |||||
| PcUbi4-2 | AtU6-26 | NHEJ, HDR | 42.8 | |||||
| Maize codon-optimized Cas9 | 2×35S | U6-26, U6-29 | NHEJ | 42—90 | ||||
| Human codon-optimized Cas9 | AtICU2 | AtU6 | NHEJ | 10.00—84.78 | ||||
| 35S | U6-26 | NHEJ | N/A | |||||
| Plant codon-optimized Cas9 | Ubi, 35S | AtU3b, AtU3d, AtU6-1, AtU6-29 | NHEJ | 81.4—90.0 | ||||
| Plant codon-optimized Cas9 | AtUBQ1, SPL | AtU6-26 | NHEJ | 3—56 | ||||
| PcUbi4-2 | AtU6-26 | NHEJ | 6.1—98.5 | |||||
| EC1.2 | U6-26p, U6-29p | NHEJ | N/A | |||||
| Human codon-optimized Cas9 | 2×35S, | AtU6-26 | NHEJ | 4.3—90.5 | ||||
| Human codon-optimized Cas9 | AtUBQ1 | AtU6-26, AtU3b, At7SL-2 | NHEJ | 13—93 | ||||
| 35S | U6-26 | NHEJ | 10 | |||||
| Human codon-optimized Cas9 | CaMV 35S | CaMV 35 S | NHEJ | 3.2—3.9 | ||||
| Plant codon-optimized Cas9 | 35S | AtU6 | NHEJ | N/A | ||||
| Plant codon-optimized Cas9 | 2×35S | AtU6 | Electroporation and transformation | NHEJ | 10.0—93.3 | |||
| Plant codon-optimized Cas9 | ZmUbi | AtU6, GmU6 | NHEJ | 11.7—48.1 | ||||
| Human codon-optimized Cas9 | 2×35S | MtU6.6 | NHEJ | >70 | ||||
| Soybean codon-optimized Cas9 | GmEF1A2 | GmU6 | Particle bombardment | NHEJ, HDR | 59—76 | |||
| Soybean codon-optimized Cas9 | 2×35S | U6 | NHEJ | N/A | ||||
| Codon-optimized cas9 | CaMV 35S | AtU6-26, GmU6-10 | NHEJ | 3.2—20.2 | ||||
| 35S | U6-26 | NHEJ | 10—23 | |||||
| Human codon-optimized Cas9 | CaMV 35S andMpEF1 | MpU6-1 | NHEJ | N/A | ||||
| Soybean codon-optimized Cas9 | 2×35S | U6 | NHEJ | N/A | ||||
| CaMV 35S | AtU6-26 | NHEJ | N/A | |||||
| Plant codon-optimized Cas9 | 35S PPDK | AtU6 | NHEJ, HDR | 9—39 | ||||
| Plant codon-optimized Cas9 | 35S | AtU3, AtU6 | NHEJ | N/A | ||||
| Human codon-optimized Cas9 | 35S | AtU6 | NHEJ | 1—3 | ||||
| Human codon-optimized Cas9 | CaMVE 3S | CaMVE35S | NHEJ | 12.7—13.8 | ||||
| Plant codon-optimized Cas9 | 35S | AtU6-26 | NHEJ | 75—85 | ||||
| Plant and Human codon-optimized Cas9 | 35S | U6-26 | NHEJ | 11 | ||||
| Plant codon-optimized Cas9 | 2×35S | AtU6-26 | NHEJ | 81.8—87.5 | ||||
| Plant codon-optimized Cas9 | 35S-PPDK | U6 | NHEJ | N/A | ||||
| Human codon-optimized Cas9 | CaMV 35S | OsU6-2 | NHEJ | 4.8—75 | ||||
| CaMV 35S | OsU6 | PEG-mediated transformation | NHEJ | N/A | ||||
| Human codon-optimized Cas9 | OsUBQ1 | OsU3 | NHEJ | 50—89 | ||||
| Rice codon-optimized Cas9 | OsUbi | OsU3 | NHEJ | 83—92 | ||||
| Rice codon-optimized Cas9 | 2×35S | OsU6 | Particle bombardment | NHEJ, HDR | 7.1—50 | |||
| Human codon-optimized Cas9 | CaMV 35S | OsU6 | NHEJ | 3—8 | ||||
| Rice codon-optimized Cas9 | 2×35S | OsU3 | Particle bombardment | NHEJ, HDR | 33—38 | |||
| Plant codon-optimized Sp Cas9 | 2×35S | AtU6-26 | NHEJ | 2—16 | ||||
| Human codon-optimized Cas9 | 35S, OsUBQ1 | OsU6, OsU3 | NHEJ | 21.1—66.7 | ||||
| Rice codon-optimized SpCas9 | OsUbi1 | OsU6 | NHEJ | 12.5—100 | ||||
| Rice codon-optimized SpCas9 | 2×P35S | OsU6 | HDR | 0.147—1 | ||||
| Rice codon-optimized SpCas9 | 2×P35S | OsU3 | NHEJ | 0—76.9 | ||||
| Plant codon optimized Cas9 | 35S | OsU3, OsU6 | NHEJ | 33.3—53.3 | ||||
| Plant codon optimized Cas9 | Ubi, 35S | OsU3, OsU6a,OsU6b, OsU6c | NHEJ | 81.4—90.0 | ||||
| Rice codon-optimized SpCas9 | 2×CaMV 35S | OsU3 | NHEJ | 7.6—68.7 | ||||
| Rice codon-optimized SpCas9 | OsU3 | OsU3 | NHEJ | N/A | ||||
| Codon-optimized SpCas9 | 2×CaMV 35S | OsU3 | NHEJ | 66.4—81.0 | ||||
| Codon-optimized Cas9 | OsUbi | OsU6a | NHEJ | 27.5—67.5 | ||||
| OsUbi | OsU6 | NHEJ | N/A | |||||
| Plant codon optimized Cas9 | 35S | AtU6 | NHEJ | 55.6—87.5 | ||||
| Wild-type SpCas9 | 35S | AtU3b, AtU3d,AtU6-1, AtU6-29 | NHEJ | 51.7 | ||||
| Codon-optimized Cas9 | 35S | AtU6 | NHEJ | N/A | ||||
| 35S | AtU6 | NHEJ | N/A | |||||
| Codon-optimized Cas9 | Ubi4 | AtU6 | NHEJ | N/A | ||||
| Human codon-optimized Cas 9 | CaMV 35S, AtUBQ | AtU6-26 | NHEJ | 72.7—100 | ||||
| 35S | AtU6 | NHEJ | 3—60 | |||||
| Rice-codon optimized Cas9 | 2×35S | StU6 | NHEJ | N/A | ||||
| Monocot codon-optimized synthetic Cas9 | Rice Actin 1 | OsU6 | NHEJ | N/A | ||||
| Human codon-optimized Cas9 | CaMVE35S | CaMVE35S | NHEJ | 18—22 | ||||
| Rice codon-optimized Cas9 | 2×35S | TaU6 | Protoplast transformation | NHEJ | 26.5—38 | |||
| Rice codon-optimized Cas9 | 2×35S | TaU6 | Particle bombardment | NHEJ | 45 | |||
| Plant codon-optimized Cas9 | Ub1 | TaU6 | Particle bombardment | NHEJ | 23—38 | |||
| SpCas9 | 35S | AtU6 | HR | 100% (suspension cell) | ||||
| Plant codon-optimized Cas9 | 2×35S | ZmU3 | NHEJ | 16.4—19.1 | ||||
| Human and Maize codon-optimized Cas9 | 2×35S, Ubi1 | AtU6-26, OsU3, TaU3 | NHEJ | N/A | ||||
| Maize codon-optimized Cas9 | Ubi | ZmU6 | NHEJ, HDR | 0.13—3.9 | ||||
| Human codon-optimized Cas9 | 2×35S | ZmU3 | NHEJ | 19—31 | ||||
| Maize codon-optimized Cas9 | ZmUbi2 | ZmU6 | NHEJ | 0.18—78.83 |
N/A, not available.
Figure 1Schematic diagram of CRISPR/Cas9 editing of target genes. (A) A sketch of CRISPR/Cas9 system. The sgRNA (black and red) can identify the target gene, and then the two domains of Cas9 (yellow) cleave the target sequence. (B) Two ways DSB can be repaired. NHEJ is imprecise and always results in a gene knockout mutation. When a template is present, HDR can be activated and results in gene replacement or knock-in. PAM, protospacer adjacent motif; sgRNA, single guide RNA; DSB, double-strand break; NHEJ, nonhomologous end-joining; HDR, homology-directed repair.
Figure 2The basic flow of CRISPR/Cas9 editing of target genes.